Certified Cardiac Medical Device Distributor

CALL 888-891-1200 Email an Order

REQUEST PRODUCT INFO

  • MED Alliance Group
  • An Experienced Medical Device Distributor

  • REQUEST PRODUCT INFO

  • MED Alliance Welcomes Airway Innovations and the AERIS Airway Device

    1. Home
    2. /
    3. Uncategorized
    4. /
    5. MED Alliance Welcomes Airway Innovations and the AERIS...

    MED Alliance Welcomes Airway Innovations and the AERIS Airway Device

    MED Alliance is pleased to announce it will represent the AERIS Airwayâ„¢ device from Airway Innovations. Airway Innovations is an Illinois-based company committed to developing airway management devices that improve patient safety, streamline the workflow of anesthesia providers, and reduce the cost of healthcare.

    Anesthesia providers typically use oxygen masks or nasal cannulas to deliver oxygen and monitor CO2. However, both devices result in inferior oxygen delivery to the supraglottis and provide unreliable ETCO2 readings due to gas mixture and dilution. Thirty-three percent of patients experience hypoxemia using these methods.

    A Breakthrough in Safer Sedation Airway Management

    Airway Innovations developed the AERIS Airway to help anesthesia providers preemptively detect and prevent hypoxemia during I.V. sedation.

    “We believe it is no longer acceptable that hypoxemia remains one of the leading causes of morbidity and mortality during anesthesia care,” said Airway Innovations CEO Paul Fehrenbacher.

    The AERIS Airway is a breakthrough in safer sedation airway management that transforms oral and nasopharyngeal airways into advanced oxygen delivery and ETCO2 monitoring devices, thereby limiting the risk of hypoxemia. By offsetting the O2 delivery port from the CO2 detection port, ETCO2 is captured at the supraglottis with minimal oxygen dilution, generating a real-time, reliable CO2 waveform on all clinical capnography monitors. Learn more.

    The device supports improved patient safety and streamlines workflow, while reducing oxygen use and overall procedural costs.

    “We are excited to add the AERIS Airway to our anesthesia portfolio and represent this innovative device in our Midwest and East Coast territories,” said MED Alliance Group President Mike Schroeder. “We are confident our customers will appreciate the benefits this transformational technology will have on patient safety and outcomes.”

    For more information or a demonstration, contact your local MED Alliance Group sales representative, call 888-891-1200 or email us.

    MED Alliance Group is dedicated to partnering with medical device companies offering high-quality, innovative products that improve patient care. We are delighted to partner with Airway Innovations and add the AERIS Airway to our portfolio.

    MED Alliance Group is a medical device distributor dedicated to meeting the needs of our clinical customers and manufacturing partners since 1998. We specialize in the sales, marketing, importation, logistics and distribution of innovative, high-quality and cost-effective products found in anesthesia and respiratory, blood and transfusion therapy, EMS and emergency room, interventional radiology and cath lab, iv and vascular, as well as NICU and PICU.

    Please follow us on LinkedIn, Facebook and Twitter for MED Alliance product updates.

  • Contact Information

  • MED Alliance Group, Inc.
    2175 Oakland Drive
    Sycamore, IL 60178

  • TOLL FREE: 888-891-1200
    PHONE: 630-443-7070

  • Copyright © 2025 MED Alliance Group, Inc. REP LOGIN PROUD MEMBER OF IMDA